146 related articles for article (PubMed ID: 9793772)
1. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial.
Barraquer RI; Alvarez de Toledo JP; Montané D; Escoto RM; Garcia Torres C; Bennani-Tazzi M
Eur J Ophthalmol; 1998; 8(3):173-8. PubMed ID: 9793772
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
Salvá P; Costa J; Andreu D; Notivol R; Martínez M
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):203-8. PubMed ID: 10389123
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac drops to treat inflammation after cataract surgery.
Herbort CP; Jauch A; Othenin-Girard P; Tritten JJ; Fsadni M
Acta Ophthalmol Scand; 2000 Aug; 78(4):421-4. PubMed ID: 10990044
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J
Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
[TBL] [Abstract][Full Text] [Related]
7. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision.
Guzey M; Karadede S; Dogan Z; Satici A
Ophthalmic Surg Lasers; 2000; 31(6):451-6. PubMed ID: 11095120
[TBL] [Abstract][Full Text] [Related]
8. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.
Kavuncu S; Horoz H; Ardagil A; Erbil HH
Int Ophthalmol; 2008 Aug; 28(4):281-5. PubMed ID: 17762913
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation.
Kraff MC; Martin RG; Neumann AC; Weinstein AJ
J Cataract Refract Surg; 1994 Mar; 20(2):138-44. PubMed ID: 8201562
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
11. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
[TBL] [Abstract][Full Text] [Related]
12. A comparison of two different formulations of diclofenac sodium 0.1% in the treatment of inflammation following cataract-intraocular lens surgery.
Mester U; Lohmann C; Pleyer U; Steinkamp G; Völcker E; Kruger H; Raj PS
Drugs R D; 2002; 3(3):143-51. PubMed ID: 12099157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction.
Koçak I; Yalvaç IS; Koçak A; Nurözler A; Unlü N; Kasim R; Duman S
Acta Ophthalmol Scand; 1998 Jun; 76(3):343-5. PubMed ID: 9686850
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group.
J Cataract Refract Surg; 1997 Oct; 23(8):1183-9. PubMed ID: 9368162
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery.
Rossetti L; Bujtar E; Castoldi D; Torrazza C; Orzalesi N
J Cataract Refract Surg; 1996; 22 Suppl 1():794-9. PubMed ID: 9279674
[TBL] [Abstract][Full Text] [Related]
16. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
Cagini C; Pellegrino A; Cerquaglia A; Iaccheri B; Lupidi M; Fiore T
Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
19. Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study.
Notivol R; Bertin D; Amin D; Whitling A; Kennedy M; Cockrum PC;
Clin Ther; 2004 Aug; 26(8):1274-85. PubMed ID: 15476908
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
Baiza-Duran LM; Quintana-Hau J; Tornero-Montaño R; Ortiz MI; Castañeda-Hernández G; Alanis-Villarreal L; Avalos-Urzua G; Bustos-Zermeño R; Domene-Hinojosa JL; Gómez-Bastar P; Ibañez-Hernandez MA; Morales-Gómez ME; Velasco-Gallegos G; Villar-Kuri J
Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
